News and views for the UB community
COVID-19 UPDATES • 1/21/2022
First-of-its-kind research with an industry partner comes when many states are restricting delta-8-THC while legalizing the more potent delta-9.
A new School of Management study sheds light on a hot Wall Street trend.
UB scientists have identified a stop switch for a motor protein called kinesin 1.
UB-educated data scientist Darshana Govind urges more women to get into a field that is producing groundbreaking research and impactful technologies.
A new study will evaluate an easier-to-use method for calculating a proper medication dose for a seizing child based on age, rather than weight.
Nichol Castro, Christopher Heffner and Thea Knowles received three of the 10 new researcher grants awarded at ASHA’s annual meeting.
An expert on the role of melatonin, the UB pharmacologist's work builds upon that of her mentor and colleague Axelrod, a Nobel Prize winner.
With omicron surging, UB infectious disease expert Thomas Russo says all masks are not created equal.
The Empire Innovation Professor of Computer Science and Engineering holds more than 85 patents as either an inventor or co-inventor.
Trends examined with machine-learning analysis could help inform public health policies.
